Management of Early-Stage Hodgkin Lymphoma
- MeSH Terms
Hodgkin Disease (C04.557.386.355); Antineoplastic Agents (D27.505.954.248); Antineoplastic Protocols (E02.183.750); Remission Induction (E02.860); Lymphoma (C04.557.386)
- Guideline Contact
- Cindy Walker-Dilks ([email protected])
- Publication Scope
- treatment
- Countries of Application
- Canada
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- PEBC (Program in evidenced-based care)
- Publication Year
- 2023
